Greek-Americans Dr. Panagiotis Anastasiadis and Dr. Antonis Kourtidis, researchers at Mayo Clinic in Florida, are seeking a cure for cancer.
Welcome, 77 artists, 40 different points of Attica welcomes you by singing Erotokritos an epic romance written at 1713 by Vitsentzos Kornaros
Thursday, September 3, 2015
Friday, August 14, 2015
Sunday, August 9, 2015
Bone marrow donor, recipient meet in Greece
At 46, never having had a health scare before, the Greece man was diagnosed with chronic lymphocytic leukemia, a type of cancer of the blood and ...
Saturday, August 8, 2015
Greek Health Minister Suggests Penalizing Cancer Patients Who Missed Screenings
Greek Health Minister Charges Cancer Patients A patient receives chemotherapy treatment for breast cancer at the Antoine-Lacassagne Cancer ...
Friday, August 7, 2015
Greek Health Minister Suggests Penalizing Cancer Patients Who Missed Screenings
Greek Health Minister Charges Cancer Patients A patient receives chemotherapy treatment for breast cancer at the Antoine-Lacassagne Cancer ...
Thursday, August 6, 2015
Greek Cancer Patients May Pay
Greek Health Minister Panayiotis Kouroublis said that people with cancer should pay part of their treatment if they weren't tested for it. The post Greek Cancer Patients May Pay appeared first on The National Herald.
Tuesday, August 4, 2015
Greek Health Ministry Considers ‘Fining’ Cancer Patients Who Didn’t Have Preventive Exams
Health Minister Panagiotis Kouroublis is considering having cancer patients pay 50 percent of treatment costs if they did not have regular preventive exams for the four prevalent types of cancer. According to a report in Elefthereos Typos daily, the ministry will establish a series of mandatory preventive exams for the four most common types of
Sunday, August 2, 2015
Ritholtz's Reads: How Germany Prevailed in the Greek Bailout
... • The Future of Cancer: Closer to a Cure. Sloan Kettering CEO Craig Thompson on the revolution under way in cancer prevention and treatment ...
Wednesday, May 27, 2015
Greek and Mediterranean diets halve womb cancer risk
Women who eat a Mediterranean diet packed with fruit, vegetables and nuts could halve their risk of getting womb cancer, scientists claim.
Friday, May 15, 2015
Greece: Relics of 3rd century Saint Barbara displayed at cancer hospital despite protests
Hundreds of worshippers have gathered at a chapel on the grounds of Greece's largest cancer hospital to view a silver chest with the remains of a 3rd century saint that has been put on display there despite protests.
Sunday, April 26, 2015
Greek Scientists Develop Cancer Drug
Greek scientists from the University of Patras are making a significant effort to help in the battle against cancer by developing an innovative drug. The research team has been working at the Pharmaceutical Chemistry Laboratory of the Department of Pharmacy at the University of Patras, led by associate professor Plato Magriotis. The team aims to create a new potent anti-cancer drug that will specialize in the treatment of sarcoma, melanoma, ovarian cancer, breast, kidney, prostate and non-microcell lung cancer. The idea behind the drug’s composition is based on a substance isolated about 48 years ago from a Caribbean marine microorganism. The substance ejected by Ecteinascidia turbinate (Et-743) is one of the most potent cytotoxins and its antineoplastic activity is much greater than that of known antitumor drugs. Et-743 is the first marine natural anti-cancer drug and was approved by the European Union in 2007. According to professor Magriotis, Et-743 causes damage to the cancer cells’ DNA and prohibits them from repairing the damage, thus further prolonging the destruction of cancer cells. “We are trying to do something different and innovative compared to what has already been done in the past and create a drug with simpler structure than that of Et-743 that will hopefully be adequate for most types of cancer. I am optimistic. This is my life’s dream. The research is on track and hopefully we will be successful fairly soon,” noted the professor.
Greek Scientists Develop Cancer Drug
patras-lab Greek scientists from the University of Patras are making a significant effort to help in the battle against cancer by developing an innovative ...
Greek Scientists Develop Cancer Drug
Greek scientists from the University of Patras are making a significant effort to help in the battle against cancer by developing an innovative drug. The research team has been working at the Pharmaceutical Chemistry Laboratory of the Department of Pharmacy at the University of Patras, led by associate professor Plato Magriotis. The team aims to create a new potent anti-cancer drug that will specialize in the treatment of sarcoma, melanoma, ovarian cancer, breast, kidney, prostate and non-microcell lung cancer. The idea behind the drug’s composition is based on a substance isolated about 48 years ago from a Caribbean marine microorganism. The substance ejected by Ecteinascidia turbinate (Et-743) is one of the most potent cytotoxins and its antineoplastic activity is much greater than that of known antitumor drugs. Et-743 is the first marine natural anti-cancer drug and was approved by the European Union in 2007. According to professor Magriotis, Et-743 causes damage to the cancer cells’ DNA and prohibits them from repairing the damage, thus further prolonging the destruction of cancer cells. “We are trying to do something different and innovative compared to what has already been done in the past and create a drug with simpler structure than that of Et-743 that will hopefully be adequate for most types of cancer. I am optimistic. This is my life’s dream. The research is on track and hopefully we will be successful fairly soon,” noted the professor.
Sunday, April 12, 2015
Aristotle University Cooperates With MIT to Find Bacteria That Fight Cancer and Autoimmune Disorders
The identification of bacteria and bacterial products that will help balance the immune system of humans and protect them against cancer and autoimmune diseases is the future goal of collaboration between the Laboratory of Pathology at the Veterinary Department of the Aristotle University of Thessaloniki, Greece, (AUTH) and the Department of Comparative Medicine at the Massachusetts Institute of Technology (MIT), Theophilos Poutahidis, associate professor at AUTH told ANA-MPA. Experiments on mice, carried out since 2002, have found bacteria in the intestinal flora, which are related to the process of carcinogenesis. In the context of cooperation between the two educational institutions, scientists found that helicobacter hepaticus (a Helicobacter that exists only in the gastrointestinal system of mice) accelerates breast and prostate cancer, whereas the Lactobacillus reuteri (a gram-positive probiotic bacterium) not only helps reduce the risk of breast cancer, but also has a positive effect on the skin and the regeneration of hair follicles, while protecting the testicles and thymus against alterations caused by aging. Moreover, Lactobacillus reuteri protected the mice from obesity, despite the consumption of food that caused it. According to Poutahidis, one of the key contributors in cooperation between AUTH and MIT, the systemic effects of subclinical inflammation, which are associated with the exposure to the risk of cancer, play a dominant role in the immune system. “The future objectives of the scientific team include a further analysis of the mechanisms of systemic effects of bowel flora on the body, the identification of the most beneficial active molecules of bacteria and clinical trials on humans. Cancer, autoimmune diseases and obesity are nowadays growing into an epidemic. Our goal is to find bacteria and bacterial products that can be consumed by humans since the first years of their life so that they can have a balanced immune system and reduce the risk of cancer and autoimmune diseases, related to the deregulation of the immune system,” he added. (source: ana-mpa)
Wednesday, April 8, 2015
Greek Police Clash With Violent Youths in Athens
When it comes to breast cancer risk, all mutations are not equal, researchers reported Tuesday. The researchers found wide variations in risk for ...
Thursday, January 8, 2015
Fundraiser in Irondequoit to aid Greece cancer patient
A benefit for Colleen Farrell, a 33-year-old Greece woman battling rectal cancer, will be held Sunday at Point Pleasant Fire Department, 55 Ewer Ave., ...
Friday, December 5, 2014
Greek Breast Cancer Information Day
Many Greek-Australian women participated in the breast cancer information day that was organized by the Breast Cancer Network of Australia in cooperation with the Greek Community of Melbourne and the Australian Social Welfare. The day’s main speakers ...
Tuesday, November 25, 2014
1 in 4 deaths caused by cancer in the EU28
by KG/EUROPA In the EU28 in 2011, cancer was the cause of death for 1.281 million persons, responsible for more than a quarter of all deaths (26.3%). Over the past ten years, while the total number of deaths slightly decreased (-0.5%), the number of deaths due to cancer increased by 6.3% (from 1.206 million in 2002 to 1.281 million in 2011), at a slightly higher pace for females (+6.6%) than for males (+6.0%). However, the number of deaths due to cancer remained higher in 2011 among the male population (718 000 deaths due to cancer) than among the female population (563 000). In 2011, cancer represented 37.1% of all causes of death for the EU28 population aged less than 65, while this level was only 23.8% for the older population (those aged 65 years and over). Leading to the death of over 266 000 persons (or 20.8% of all deaths due to cancer), lung cancer was the main type of fatal cancer in the EU28 in 2011, followed by colorectal cancer (152 000 or 11.9%), breast cancer (93 000 or 7.2%), pancreas cancer (78 000 or 6.1%) and prostate cancer (73 000 or 10.2% of all fatal cancers for the male population only). This information is published by Eurostat, the statistical office of the European Union. Cancer: responsible for nearly 40% of deaths among those aged less than 65, and under 25% amongst those aged 65 and over Among the total population, cancer was in 2011 the cause of more than 30% of deaths in the Netherlands (31.9%), Slovenia (31.3%) and Ireland (30.5%), while it represented less than a fifth of all causes of death in Bulgaria (15.6%), Romania (19.1%) and Lithuania (19.9%). At least a quarter of deaths were due to cancer in seventeen Member States in 2011. Looking at age groups, 345 000 persons aged less than 65 died in 2011 in the EU28 because of cancer, meaning that cancers represented more than a third (37.1%) of all causes of death for this age group. Among Member States, death due to cancer for people aged less than 65 accounted for more than 40% of all causes of death in the Netherlands (48.0%), Italy (45.2%), Spain (43.9%) and Slovenia (40.9%), but less than 30% in Lithuania (23.2%), Latvia (24.2%), Estonia (26.3%), Bulgaria (26.7%) and Finland (28.4%). For the population aged 65 and over, cancer represented almost a quarter (23.8% or 936 000 persons) of all causes of deaths in the EU28 in 2011, with the highest shares registered in Slovenia (28.8%), Ireland (28.4%), the Netherlands (28.3%), Denmark (27.6%) and the United Kingdom (27.2%), and the lowest in Bulgaria (12.3%) and Romania (15.2%). Highest proportion of both fatal lung cancer and colorectal cancer in Hungary In all Member States, the most prevalent cancer leading to death in 2011 was lung cancer, except in Portugal where it was colorectal cancer. The highest proportions of lung cancer among all deaths due to cancer were recorded in Hungary (26.1%), the Netherlands (24.6%), Belgium (24.5%) Greece and Poland (both 24.1%), and the lowest in Portugal (14.5%), Sweden (16.7%), Latvia (16.8%), Lithuania and Slovakia (both 17.1%). Compared with 2002, the proportions of lung cancer among all deaths due to cancer increased in fourteen Member States, decreased in ten and remained almost stable in Slovenia and Finland. In 2011, the highest proportions of deaths due to colorectal cancer among all deaths due to cancer were registered in Hungary (15.5%), Slovakia (15.3%), Portugal (15.0%), Croatia (14.7%) and Spain (14.6%). On the opposite end of the scale, colorectal cancer represented less than 10% of all deaths due to cancer in Cyprus (7.9%), Greece (8.9%) and Finland (9.8%). Highest proportion of fatal prostate cancer in the Nordic Member States Prostate cancer represented in 2011 the fifth main type of fatal cancer in the EU28, with a 5.7% share in all deaths due to cancer. Prostate cancer however only affects men, for whom it caused 10.2% of all deaths due to cancer in 2011 in the EU28. Among Member States, the highest shares were observed in the three Nordic Member States: Sweden (11.0% of deaths due to cancer in the total population, and 20.9% of all deaths due to cancer among the male population), Denmark (7.9% and 15.1%) and Finland (7.6% and 14.4%). On the contrary, shares of less than 5% of all deaths due to cancer in the total population were recorded in Hungary (3.7% of deaths due to cancer in the total population, and 6.7% of all deaths due to cancer among the male population), Malta (4.0% and 7.4%), Romania (4.1% and 6.9%), Poland (4.4% and 7.9%), Italy (4.5% and 8.0%), Luxembourg (4.7% and 8.6%), the Czech Republic (4.8% and 8.7%) and Slovakia (4.9% and 8.4%).
Wednesday, October 29, 2014
Greek Life Supports the Fight Against Breast Cancer
The Greek community of NJIT participated in the Making Strides Against Breast Cancer Walk, as they do every year. It was a brisk Sunday morning as ...
Monday, September 29, 2014
Canada-Greece Partnership for Paediatric Cancer Initiative
SickKids in Toronto has started a new partnership with the Oncology Department of Aghia Sofia Children's Hospital in Athens.